Ichor Holdings
ICHR
$83.74
-10.12%
Ichor Holdings designs, engineers, and manufactures critical fluid delivery subsystems and components primarily for semiconductor capital equipment, with additional solutions for defense/aerospace and medical industries. The company is a niche player in the semiconductor supply chain, specializing in gas and chemical delivery systems that enable precise control in manufacturing processes like etch and cleaning. The current investor narrative centers on a dramatic turnaround, as the stock has surged over 300% in the past year amid a cyclical recovery in semiconductor capital spending and improving financial performance, with recent quarterly revenue growing 4.75% year-over-year and narrowing losses. Debate remains around the sustainability of this growth trajectory and the company's path to sustained profitability.…
ICHR
Ichor Holdings
$83.74
Investment Opinion: Should I buy ICHR Today?
Rating: Hold. Ichor Holdings is a compelling turnaround story with strong momentum, but the stock's 305% run and limited upside to the average analyst target of $92.29 suggest much of the good news is already priced in. The consensus 'strong buy' rating is bullish, but the flat target price indicates limited near-term upside.
Supporting Evidence: Revenue grew 4.75% YoY to $256.1M and 14.5% sequentially, showing accelerating demand. Operating margin improved to 1.1% from -6.2% in the prior quarter, demonstrating operational leverage. The trailing P/S of 0.68x is a deep discount to the industry average of 3-5x, but this is justified by negative profitability. Free cash flow remains negative at -$9.98M in Q1 2026, highlighting the need for continued improvement.
Risks & Conditions: The biggest risks are failure to achieve sustained profitability, a reversal in the semiconductor cycle, and the stock's high beta amplifying downside. This Hold would upgrade to Buy if the company reports positive net income and free cash flow, or if the P/S compresses below 0.5x. It would downgrade to Sell if revenue growth decelerates below 5% YoY or gross margins fail to improve above 15%. Overall, Ichor appears fairly valued relative to its current earnings power, but undervalued on a forward P/S basis if the turnaround succeeds.
Sign up to view all
ICHR 12-Month Price Forecast
Ichor Holdings is in the early stages of a cyclical recovery, with improving revenue and margins. However, the stock has already priced in much of the optimism, as reflected in the flat analyst target. The base case of continued gradual improvement is most likely, but the risk/reward is balanced given the high volatility and lack of profitability. A neutral stance is warranted until the company demonstrates sustained positive earnings and free cash flow, which would provide a clearer catalyst for further upside.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ichor Holdings's 12-month outlook, with a consensus price target around $92.29 and implied upside of +10.2% versus the current price.
Average Target
$92.29
0 analysts
Implied Upside
+10.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$60 - $125
Analyst target range
Ichor Holdings is covered by 7 analysts, with a consensus recommendation of 'strong buy' (mean rating 1.43 on a 1-5 scale). The average target price is $92.29, which is essentially flat relative to the current price of $93.17, implying a slight downside of -0.9%. The distribution shows 6 buys and 1 hold (Oppenheimer rates it 'Perform'), indicating a bullish tilt but with limited upside to the average target. The target range spans from a low of $60.00 to a high of $125.00. The high target of $125 assumes a successful execution of the growth strategy, potentially driven by further market share gains in semiconductor fluid delivery and margin expansion as revenue scales. The low target of $60 implies a scenario where the cyclical recovery stalls or competition intensifies, leading to margin compression and a re-rating lower. Recent analyst actions have been positive: Stifel upgraded from Hold to Buy in March 2026, and multiple firms (B. Riley, Needham, TD Cowen) reiterated Buy ratings in May and June 2026. The wide spread between the low and high targets ($60 to $125) reflects high uncertainty about the company's future performance, typical of a turnaround story with volatile earnings. The limited coverage (7 analysts) is consistent with a small-cap stock, which can lead to higher volatility and less efficient price discovery.
Bulls vs Bears: ICHR Investment Factors
Ichor Holdings presents a classic turnaround story with strong momentum: revenue is accelerating, operating margins have turned positive, and the stock trades at a deep discount to peers on a P/S basis. However, the company remains unprofitable with negative free cash flow, low gross margins, and limited upside to the average analyst target. The bull case hinges on continued cyclical recovery in semiconductor capex driving revenue growth and margin expansion, while the bear case centers on the risk that profitability remains elusive or that the stock's 305% run has already priced in the recovery. The single most important tension is whether Ichor can convert revenue growth into sustainable positive net income and free cash flow, which would validate the current valuation and support further upside.
Bullish
- Revenue recovery accelerating: Q1 2026 revenue of $256.1M grew 4.75% YoY and 14.5% sequentially from Q4 2025, signaling a strong cyclical upturn in semiconductor capital spending. This marks a clear inflection from the trough of $203.2M in Q2 2024.
- Operating margin turns positive: Operating margin improved to 1.1% in Q1 2026 from -6.2% in Q4 2025, demonstrating operational leverage as revenue scales. This is a critical milestone on the path to sustained profitability.
- Analyst consensus is strong buy: 7 analysts rate Ichor a 'strong buy' with a mean rating of 1.43/5. Recent upgrades (Stifel from Hold to Buy) and reiterated Buy ratings from B. Riley, Needham, and TD Cowen reflect growing confidence in the turnaround.
- Low valuation relative to peers: Trailing P/S of 0.68x is well below the semiconductor industry average of 3-5x and near the bottom of its historical range of 1.9x-6.4x. This deep discount implies significant upside if profitability materializes.
Bearish
- Still unprofitable with negative FCF: Net income was -$2.5M in Q1 2026 and TTM free cash flow is -$16.8M. Despite revenue growth, the company has not yet achieved sustained profitability, raising questions about the durability of the turnaround.
- Low gross margins persist: Gross margin of 11.6% in Q1 2026 is far below the semiconductor equipment industry norm of 40%+. This structural weakness limits earnings power even as revenue grows.
- Limited upside to analyst target: The average analyst target of $92.29 is essentially flat to the current price of $93.17, implying -0.9% downside. This suggests the stock may already reflect optimistic expectations.
- High beta and volatility risk: Beta of 1.783 makes Ichor 78% more volatile than the market. The stock has already surged 305% in the past year, making it vulnerable to sharp pullbacks on any negative news or macro shock.
ICHR Technical Analysis
Ichor Holdings is in a powerful sustained uptrend, with the stock price up 305.4% over the past year. The current price of $93.17 sits at 82.0% of its 52-week range ($13.12 - $113.58), indicating the stock is trading near the upper end of its range, reflecting strong momentum but also potential overextension. The 52-week low of $13.12 and high of $113.58 provide a wide band, with the current price closer to the high, suggesting bullish sentiment dominates. Short-term momentum is accelerating, with a 1-month price change of +4.1% and a 3-month change of +46.3%, both outpacing the S&P 500's respective gains of 0.6% and 6.3%. This divergence from the broader market highlights Ichor's strong relative strength (relative strength 1-month: 3.5, 3-month: 40.0). The 1-month trend is positive but decelerating compared to the explosive 3-month move, which could signal a consolidation phase or a temporary pullback before the next leg higher. The stock's beta of 1.783 indicates it is 78.3% more volatile than the market, amplifying both upside and downside moves. Key support lies near the 52-week low of $13.12, while resistance is at the 52-week high of $113.58. A breakout above $113.58 would signal a continuation of the uptrend, potentially targeting new highs, while a breakdown below recent support around $85 (the July 7 low) could trigger a deeper correction. The high beta suggests aggressive position sizing should be managed carefully.
Beta
1.78
1.78x market volatility
Max Drawdown
-40.8%
Largest decline past year
52-Week Range
$13-$114
Price range past year
Annual Return
+270.5%
Cumulative gain past year
| Period | ICHR Return | S&P 500 |
|---|---|---|
| 1m | -2.4% | +0.1% |
| 3m | +27.4% | +5.7% |
| 6m | +181.2% | +8.5% |
| 1y | +270.5% | +20.3% |
| ytd | +310.3% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ICHR Fundamental Analysis
Revenue has shown a steady recovery, with Q1 2026 revenue of $256.1 million, up 4.75% year-over-year from $244.5 million in Q1 2025. This marks an acceleration from the prior quarter's revenue of $223.6 million (Q4 2025) and a significant improvement from the trough in Q2 2024 ($203.2 million). The sequential growth of 14.5% from Q4 2025 to Q1 2026 indicates strengthening demand, likely driven by the semiconductor cycle upturn. However, the company remains unprofitable, with net income of -$2.5 million in Q1 2026, though this is a substantial improvement from -$15.9 million in Q4 2025 and -$22.9 million in Q3 2025. Gross margin improved to 11.6% in Q1 2026 from 9.4% in Q4 2025, but remains low relative to the semiconductor equipment industry, where gross margins typically exceed 40%. Operating margin turned positive at 1.1% in Q1 2026, compared to -6.2% in Q4 2025, signaling operational leverage as revenue grows. The balance sheet shows a healthy current ratio of 3.16 and a low debt-to-equity ratio of 0.28, indicating minimal financial leverage. However, free cash flow was negative -$9.98 million in Q1 2026, and trailing twelve-month free cash flow is -$16.8 million, suggesting the company is still consuming cash to fund operations and growth. Return on equity is -7.95%, reflecting ongoing losses, but the trend is improving as losses narrow.
Quarterly Revenue
$256067999.0B
2026-03
Revenue YoY Growth
+4.8%
YoY Comparison
Gross Margin
11.6%
Latest Quarter
Free Cash Flow
$-16761000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ICHR Overvalued?
Since net income is negative (TTM net income of -$24.7 million), the trailing P/E ratio of -12.3 is not meaningful. Therefore, we use the price-to-sales (P/S) ratio as the primary valuation metric. The trailing P/S ratio is 0.68x, based on a market cap of $648.7 million and TTM revenue of approximately $948 million. The forward P/S (using estimated revenue of $2.01 billion) would be 0.32x, implying a significant discount if revenue growth materializes. Compared to the semiconductor industry average P/S of roughly 3-5x, Ichor trades at a steep discount—about 80% below the industry median. This discount is likely justified by the company's negative profitability and low gross margins, but it also suggests upside potential if the company can achieve sustained profitability. Historically, Ichor's P/S ratio has ranged from 1.9x to 6.4x over the past five years. The current 0.68x is near the bottom of its historical range, which could indicate a value opportunity if the turnaround gains traction. However, the low multiple also reflects the market's skepticism about the durability of the recovery and the company's ability to generate consistent profits.
PE
-12.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-98.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ichor's primary financial risk is its lack of profitability, with a TTM net loss of -$24.7M and negative free cash flow of -$16.8M. The company's gross margin of 11.6% is structurally low compared to industry peers, limiting earnings leverage. While the debt-to-equity ratio of 0.28 is manageable, the reliance on continued revenue growth to achieve profitability means any slowdown could delay the path to positive earnings. The current ratio of 3.16 provides liquidity, but cash burn from operations remains a concern if the cyclical recovery falters.
Market & Competitive Risks: The stock's high beta of 1.783 amplifies sensitivity to macro conditions, particularly semiconductor industry cycles. With the stock up 305% in the past year, valuation compression risk is elevated if the recovery disappoints. The P/S of 0.68x, while low, reflects market skepticism about profitability. Competitive risks include potential market share loss in fluid delivery subsystems and pricing pressure from larger players. The limited analyst coverage (7 analysts) and small-cap status contribute to higher volatility and less efficient price discovery.
Worst-Case Scenario: If the semiconductor cycle reverses or Ichor fails to achieve sustained profitability, the stock could re-rate lower. The 52-week low of $13.12 represents a -85.9% decline from the current price of $93.17. While a drop to that extreme is unlikely given the improved fundamentals, a more realistic bear case is the analyst low target of $60, implying a -35.6% loss. Historical max drawdown of -40.8% suggests that a correction of similar magnitude would bring the stock to around $55, consistent with the low target.
FAQ
The key risks are: 1) Financial risk: Ichor is still unprofitable with TTM net loss of -$24.7M and negative free cash flow of -$16.8M, making it vulnerable to any slowdown. 2) Cyclical risk: As a semiconductor equipment supplier, Ichor is highly sensitive to the capital spending cycle; a downturn could sharply reduce revenue. 3) Valuation risk: The stock has surged 305% in the past year, and the average analyst target offers no upside, suggesting it may be fully priced. 4) Volatility risk: With a beta of 1.783, the stock is 78% more volatile than the market, amplifying losses during downturns. The most severe risk is a cyclical reversal that could drive the stock to $60 or lower.
The 12-month forecast for Ichor Holdings is balanced across three scenarios. The base case (50% probability) assumes continued gradual recovery, with the stock trading around $80-$100, near the average analyst target of $92.29. The bull case (25% probability) sees accelerating growth and margin expansion, pushing the stock to $100-$125, the high analyst target. The bear case (25% probability) involves a cyclical downturn or failure to achieve profitability, driving the stock to $60-$80, near the low target of $60. The most likely scenario is the base case, where the company continues to improve but the stock remains range-bound as the market waits for proof of sustained profitability.
Ichor Holdings appears undervalued on a price-to-sales basis, with a trailing P/S of 0.68x compared to the semiconductor industry average of 3-5x. This discount reflects the company's negative profitability and low gross margins of 11.6%. Historically, Ichor's P/S has ranged from 1.9x to 6.4x, so the current multiple is near the bottom of its range, suggesting potential upside if the turnaround succeeds. However, the stock is not cheap on an earnings basis, with a negative P/E and a forward P/E of 34.5x based on estimated EPS of $3.87. The market is pricing in a significant recovery, and the valuation implies that investors expect sustained profitability improvements.
Ichor Holdings is a high-risk, high-reward stock that may be suitable for aggressive investors with a long-term horizon and tolerance for volatility. The stock has strong momentum, with revenue accelerating 4.75% YoY and operating margins turning positive. However, the average analyst target of $92.29 is essentially flat to the current price of $93.17, suggesting limited near-term upside. The biggest downside risk is a reversal in the semiconductor cycle, which could send the stock to the low target of $60 (-35.6%). For investors who believe the cyclical recovery has further to run, Ichor offers a deep value entry on a P/S basis, but it is not a buy for those seeking immediate returns or capital preservation.
Ichor Holdings is best suited for long-term investors who can tolerate high volatility and have a multi-year horizon. The company is in a cyclical recovery phase, and the stock's high beta of 1.783 makes it prone to sharp swings, which is less suitable for short-term trading. The lack of dividends and negative free cash flow mean there is no income cushion. A minimum holding period of 2-3 years is recommended to allow the semiconductor cycle to play out and for the company to demonstrate sustained profitability. Short-term traders may find opportunities in the stock's momentum, but the risk of a sharp pullback is significant given the 305% run-up.